Issue
SICOT-J
Volume 10, 2024
Special issue: "Bone and joint infections"
Article Number 19
Number of page(s) 9
Section Hip
DOI https://doi.org/10.1051/sicotj/2024008
Published online 30 May 2024
  1. Henderson ER, Groundland JS, Pala E, Dennis JA, Wooten R, Cheong D, Windhager R, Kotz RI, Mercuri M, Funovics PT, Hornicek FJ, Temple HT, Ruggieri P, Letson GD (2011) Failure mode classification for tumor endoprostheses: Retrospective review of five institutions and a literature review. J Bone Joint Surg 93, 418–429. [Google Scholar]
  2. Jeys LM, Grimer RJ, Carter SR, Tillman RM (2005) Periprosthetic infection in patients treated for an orthopaedic oncological condition. JBJS 87(4), 842–849. [Google Scholar]
  3. Racano A, Pazionis T, Farrokhyar F, Deheshi B, Ghert M (2013) High infection rate outcomes in long-bone tumor surgery with endoprosthetic reconstruction in adults: A systematic review. Clin Orthop 471, 2017–2027. [Google Scholar]
  4. Shehadeh A, Noveau J, Malawer M, Henshaw R (2010) Late complications and survival of endoprosthetic reconstruction after resection of bone tumors. Clin Orthop 468, 2885–2895. [Google Scholar]
  5. Graci C, Maccauro G, Muratori F, Spinelli MS, Rosa MA, Fabbriciani C (2010) Infection following bone tumor resection and reconstruction with tumoral prostheses: A literature review. Int J Immunopathol Pharmacol 23, 1005–1013. [Google Scholar]
  6. Jeys L, Grimer R (2009) The long-term risks of infection and amputation with limb salvage surgery using endoprostheses, in Treatment of Bone and Soft Tissue Sarcomas. Tunn P-U, Editor. Springer: Berlin, Heidelberg. pp. 75–84. [Google Scholar]
  7. Kapoor SK, Thiyam R (2015) Management of infection following reconstruction in bone tumors. J Clin Orthop Trauma 6, 244–251. [Google Scholar]
  8. Hardes J, Ahrens H, Gosheger G, Nottrott M, Dieckmann R, Henrichs M-P, Streitbürger A. (2014) Komplikationsmanagement bei Megaprothesen. Unfallchirurg 117, 607–613. [Google Scholar]
  9. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. J Clin Epidemiol 62, 1006–1012. [Google Scholar]
  10. Khakzad T, Karczewski D, Thielscher L, Reiter K, Wittenberg S, Paksoy A, Flörcken A, Rau D, Märdian S (2022) Prosthetic joint infection in mega-arthroplasty following shoulder, hip and knee malignancy – a prospective follow-up study. Life 12, 2134. [Google Scholar]
  11. Berger C, Larsson S, Bergh P, Brisby H, Wennergren D (2021) The risk for complications and reoperations with the use of mega prostheses in bone reconstructions. J Orthop Surg 16, 598. [Google Scholar]
  12. Fujiwara T, Ebihara T, Kitade K, Setsu N, Endo M, Iida K, Matsumoto Y, Matsunobu T, Oda Y, Iwamoto Y, Nakashima Y (2020) Risk factors of periprosthetic infection in patients with tumor prostheses following resection for musculoskeletal tumor of the lower limb. J Clin Med 9, 3133. [Google Scholar]
  13. Streitbuerger A, Henrichs MP, Hauschild G, Nottrott M, Guder W, Hardes J (2019) Silver-coated megaprostheses in the proximal femur in patients with sarcoma. Eur J Orthop Surg Traumatol 29, 79–85. [Google Scholar]
  14. Parry MC, Laitinen MK, Albergo JI, Gaston CL, Stevenson JD, Grimer RJ, Jeys LM (2019) Silver-coated (Agluna®) tumour prostheses can be a protective factor against infection in high risk failure patients. Eur J Surg Oncol 45, 704–710. [Google Scholar]
  15. Medellin MR, Fujiwara T, Clark R, Stevenson JD, Parry M, Jeys L (2019) Mechanisms of failure and survival of total femoral endoprosthetic replacements. Bone Joint J. 101-B, 522–528. [Google Scholar]
  16. Hardes J, Henrichs MP, Hauschild G, Nottrott M, Guder W, Streitbuerger A (2017) Silver-coated megaprosthesis of the proximal tibia in patients with sarcoma. J Arthroplasty 32, 2208–2213. [Google Scholar]
  17. Dhanoa A, Ajit Singh V, Elbahri H (2015) Deep infections after endoprosthetic replacement operations in orthopedic oncology patients. Surg Infect 16, 323–332. [Google Scholar]
  18. Mavrogenis AF, Pala E, Angelini A, Calabro T, Romagnoli C, Romantini M, Drago G, Ruggieri P (2015) Infected prostheses after lower-extremity bone tumor resection: Clinical outcomes of 100 patients. Surg Infect 16, 267–275. [Google Scholar]
  19. Allison D, Huang E, Ahlmann ER, Carney S, Wang L, Menendez LR (2014) Peri-prosthetic infection in the orthopedic tumor patient. Reconstr Rev 4, 13–22. [Google Scholar]
  20. Peel T, May D, Buising K, Thursky K, Slavin M, Choong P (2014) Infective complications following tumour endoprosthesis surgery for bone and soft tissue tumours. Eur. J. Surg. Oncol. 40, 1087–1094. [Google Scholar]
  21. Funovics PT, Hipfl C, Hofstaetter JG, Puchner S, Kotz RI, Dominkus M (2011) Management of septic complications following modular endoprosthetic reconstruction of the proximal femur. Int Orthop 35, 1437–1444. [Google Scholar]
  22. Morii T, Yabe H, Morioka H, Beppu Y, Chuman H, Kawai A, Takeda K, Kikuta K, Hosaka S, Yazawa Y, Takeuchi K, Anazawa U, Mochizuki K, Satomi K (2010) Postoperative deep infection in tumor endoprosthesis reconstruction around the knee. J Orthop Sci 15, 331–339. [Google Scholar]
  23. Gosheger G, Gebert C, Ahrens H, Streitbuerger A, Winkelmann W, Hardes J (2006) Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop 450, 164–171. [Google Scholar]
  24. Theil C, Schwarze J, Gosheger G, Moellenbeck B, Schneider KN, Deventer N, Klingebiel S, Grammatopoulos G, Boettner F, Schmidt-Braekling T (2022) Implant survival, clinical outcome and complications of megaprosthetic reconstructions following sarcoma resection. Cancers 14, 351. [Google Scholar]
  25. Holm CE, Soerensen MS, Yilmaz M, Petersen MM (2022) Evaluation of tumor-prostheses over time: Complications, functional outcome, and comparative statistical analysis after resection and reconstruction in orthopedic oncologic conditions in the lower extremities. SAGE Open Med 10, 205031212210941. [Google Scholar]
  26. Pannu TS, Villa JM, Higuera CA (2021) Diagnosis and management of infected arthroplasty. SICOT J 7, 54. [Google Scholar]
  27. Sambri A, Maso A, Storni E, Megaloikonomos PD, Igoumenou VG, Errani C, Mavrogenis AF, Bianchi G (2019) Sonication improves the diagnosis of megaprosthetic infections. Orthopedics 42, 28–32. [Google Scholar]
  28. Izakovicova P, Borens O, Trampuz A (2019) Periprosthetic joint infection: current concepts and outlook. EFORT Open Rev 4, 482–494. [Google Scholar]
  29. Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ, Garvin KL, Mont MA, Wongworawat MD, Zalavras CG (2011) New definition for periprosthetic joint infection: from the workgroup of the musculoskeletal infection society. Clin Orthop 469, 2992–2994. [Google Scholar]
  30. Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR (2013) Diagnosis and management of prosthetic joint infection: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 56, e1–e25. [Google Scholar]
  31. Tsantes AG, Altsitzioglou P, Papadopoulos DV, Lorenzo D, Romanò CL, Benzakour T, Tsukamoto S, Errani C, Angelini A, Mavrogenis AF (2023) Infections of tumor prostheses: An updated review on risk factors, microbiology, diagnosis, and treatment strategies. Biology 12, 314. [Google Scholar]
  32. Mavrogenis AF, Papagelopoulos PJ, Coll-Mesa L, Pala E, Guerra G, Ruggieri P (2011) Infected tumor prostheses. Orthopedics 34, 991–998. [Google Scholar]
  33. Ferry T, Batailler C, Brosset S, Kolenda C, Goutelle S, Sappey-Marinier E, Josse J, Laurent F, Lustig S, On Behalf of the Lyon BJI Study Group (2020) Medical innovations to maintain the function in patients with chronic PJI for whom explanation is not desirable: a pathophysiology-, multidisciplinary-, and experience-based approach. SICOT J 6, 26. [Google Scholar]
  34. Bolia IK, Tsiodras S, Chloros GD, Kaspiris A, Sarlikiotis T, Savvidou OD, Papagelopoulos PJ (2018) A review of novel antibiotic regimens for the treatment of orthopedic infections. Orthopedics 41, 323–328. [Google Scholar]
  35. Qasim SN, Swann A, Ashford R (2017) The DAIR (debridement, antibiotics and implant retention) procedure for infected total knee replacement – a literature review. SICOT J 3, 2. [Google Scholar]
  36. Gundavda MK, Katariya A, Reddy R, Agarwal MG (2020) Fighting megaprosthetic infections: What are the chances of winning? Indian J Orthop 54, 469–476. [Google Scholar]
  37. Bejon P, Berendt A, Atkins BL, Green N, Parry H, Masters S, Mclardy-Smith P, Gundle R, Byren I (2010) Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology. J Antimicrob Chemother 65, 569–575. [Google Scholar]
  38. Gitelis S, Yergler JD, Sawlani N, Schiff A, Shott S (2008) Short and long term failure of the modular oncology knee prosthesis. Orthopedics 31, 362. [Google Scholar]
  39. Sukeik M, Haddad FS (2019) Periprosthetic joint infections after total hip replacement: an algorithmic approach. SICOT J 5, 5. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  40. Fontalis A, Berry DJ, Shimmin A, Slullitel PA, Buttaro MA, Li C, Malchau H, Haddad FS (2021) Prevention of early complications following total hip replacement. SICOT J 7, 61. [Google Scholar]
  41. Miwa S, Shirai T, Yamamoto N, Hayashi K, Takeuchi A, Tada K, Kajino Y, Inatani H, Higuchi T, Abe K, Taniguchi Y, Tsuchiya H (2017) Risk factors for postoperative deep infection in bone tumors. PLOS One 12, e0187438. [Google Scholar]
  42. Pugh LR, Clarkson PW, Phillips AE, Biau DJ, Masri BA (2014) Tumor endoprosthesis revision rates increase with peri-operative chemotherapy but are reduced with the use of cemented implant fixation. J Arthroplasty 29, 1418–1422. [Google Scholar]
  43. Haijie L, Dasen L, Tao J, Yi Y, Xiaodong T, Wei G (2018) Implant survival and complication profiles of endoprostheses for treating tumor around the knee in adults: a systematic review of the literature over the past 30 years. J Arthroplasty 33, 1275–1287. [Google Scholar]
  44. De Gori M, Gasparini G, Capanna R (2017) Risk factors for perimegaprosthetic infections after tumor resection. Orthopedics 40, e11–e16. [Google Scholar]
  45. Mavrogenis AF, Pala E, Angelini A, Ferraro A, Ruggieri P (2013) Proximal tibial resections and reconstructions: Clinical outcome of 225 patients. J Surg Oncol 107, 335–342. [Google Scholar]
  46. Grimer RJ, Carter SR, Tillman RM, Sneath RS, Walker PS, Unwin PS, Shewell PC (1999) Endoprosthetic replacement of the proximal tibia. J Bone Joint Surg Br 81-B, 488–494. [Google Scholar]
  47. Cho WH, Song WS, Jeon D-G, Kong C-B, Kim JI, Lee S-Y (2012) Cause of infection in proximal tibial endoprosthetic reconstructions. Arch Orthop Trauma Surg 132, 163–169. [Google Scholar]
  48. Ozaki T, Hoffmann C, Hillmann A, Gosheger G, Lindner N, Winkelmann W (2002) Implantation of hemipelvic prosthesis after resection of sarcoma. Clin Orthop 396, 197–205. [Google Scholar]
  49. Pala E, Mavrogenis AF, Angelini A, Henderson ER, Douglas Letson G, Ruggieri P (2013) Cemented versus cementless endoprostheses for lower limb salvage surgery. J Balk Union Oncol 18, 496–503. [Google Scholar]
  50. Lex JR, Koucheki R, Stavropoulos NA, Michele JD, Toor JS, Tsoi K, Ferguson PC, Turcotte RE, Papagelopoulos PJ (2022) Megaprosthesis anti-bacterial coatings: A comprehensive translational review. Acta Biomater 140, 136–148. [Google Scholar]
  51. Savvidou OD, Kaspiris A, Trikoupis I, Kakouratos G, Goumenos S, Melissaridou D, Papagelopoulos PJ (2020) Efficacy of antimicrobial coated orthopaedic implants on the prevention of periprosthetic infections: A systematic review and meta-analysis. J Bone Joint Infect 5, 212–222. [Google Scholar]
  52. Fiore M, Sambri A, Zucchini R, Giannini C, Donati DM, De Paolis M (2021) Silver-coated megaprosthesis in prevention and treatment of peri-prosthetic infections: A systematic review and meta-analysis about efficacy and toxicity in primary and revision surgery. Eur J Orthop Surg Traumatol 31, 201–220. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.